0%
0%
0%
0%
0%
About Dermata Therapeutics, Inc
Sector
Health Technology
Industry
Pharmaceuticals: Major
CEO
Gerald T. Proehl
Website
dermatarx.com
Headquarters
San Diego
Employees
8
Founded
2014
ISIN
US2498453065
Dermata Therapeutics, Inc. is a clinical-stage medical dermatology company that focuses on identifying, developing, and commercializing pharmaceutical product candidates for the treatment of medical and aesthetic skin diseases. Its product pipeline includes DMT310, DMT400, and DMT410. The company was founded by David F. Hale and Gerald T. Proehl on December 8, 2014 and is headquartered in San Diego, CA.
This info isn't a recommendation for what you should personally do, so please don't take the data as investment advice. As with any trade, always look first, then leap. Read more in the Terms of Use.
